-
Mashup Score: 3
Drs. Lonial, Nabhan, and Stewart discussed the plenary session at ASH 2023, the PERSEUS trial, and treating smoldering MM.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 6The HemOnc Pulse Live | Blood Cancers Today - 19 hour(s) ago
Hosted by Chadi Nabhan, MD, the inaugural HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 3-4 in Chicago.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
π We're only a few days away from #HOPLive24! ποΈ Whether you're looking forward to the #bispecifics panel with @Rfonsi1, @mrbishop_UC_BMT, & @AaronGoodman33, or the #AML panel with @Daver_Leukemia & @MikkaelSekeres, there's lots in store! π Learn more: https://t.co/MydFt6GkqD https://t.co/3BeiSNz1vO
-
-
Mashup Score: 1SIMPLIFY-1: Momelotinib Leads to Higher Transfusion Independence in MF | Blood Cancers Today - 2 day(s) ago
Momelotinib achieved higher rates of transfusion independence compared with ruxolitinib.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 2Epcoritamab Produces Promising Responses in Patients With Follicular Lymphoma | Blood Cancers Today - 2 day(s) ago
Subcutaneous epcoritamab monotherapy yielded deep responses with promising response rates in high-risk relapsed or refractory follicular lymphoma.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 3Molly Stoddart, RN, BSN, on Clinical Research Nursing in Multiple Myeloma | Blood Cancers Today - 2 day(s) ago
Molly Stoddart, RN, BSN, a clinical research nurse on the multiple myeloma team at the Winship Cancer Institute at Emory, shares her experiences.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 24Subscribe | Blood Cancers Today - 3 day(s) ago
Sign up for Blood Cancers Today eNewsletters to join an extensive community of hematologic oncology professionals and get the latest news and insights from the field.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 7Mosunetuzumab Continually Shows Safety, Efficacy in Relapsed or Refractory Follicular Lymphoma | Blood Cancers Today - 3 day(s) ago
Intravenous mosunetuzumab was administered in 21-day cycles, with step-up dosing integrated in cycle one.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Prefibrotic myelofibrosis is the focus of βSOHO State of the Art Updates and Next Questions.β
Source: bloodcancerstoday.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3Indolent B-Cell Lymphoma | Blood Cancers Today - 5 day(s) ago
Indolent B-cell lymphoma consists of slow-growing non-Hodgkin lymphomas that form in B cells, including follicular lymphoma, hairy cell leukemia, and marginal zone lymphoma.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 14FLT3 Gene Cluster Expression, Not FLT3 Mutation Status Predicts Quizartinib Response in AML | Blood Cancers Today - 5 day(s) ago
Benefit from treatment with quizartinib was accurately predicted by a βFLT3-likeβ gene expression signature identified in patients with acute myeloid leukemia.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
Treatment benefit from the FLT3 inhibitor quizartinib was predicted by a βFLT3-likeβ gene expression signature identified in patients with #AML both with and without FLT3 mutations, according to a study led by @MosqueraOrgeira of @UniversidadeUSC. π https://t.co/8zCXWlajcx https://t.co/a3rVPvm68N
-
Should physicians treat smoldering multiple myeloma? π€ @akeithstewart, and BCT's very own @SagarLonialMD, join @chadinabhan to talk about both sides of the debate. β‘οΈ https://t.co/yWvCsEA0Vi https://t.co/hBoSseD8zc